For instance, valproic acid is predicted to interact with NTF3, while dexamethasone is associated with VCAM1, suggesting that these genes could serve as potential therapeutic targets for modulating gene activity in the treatment of keloids (Figures 13C–F). The gene discussed is VCAM1; the disease is keloid.